1. Specific recommendations for prevention strategies often depend on the ischemic
stroke/transient ischemic attack subtype. Therefore, new in this guideline is a section …

Aim Current guidelines recommend the use of vitamin K antagonist (VKA) for up to 3–6
months for treatment of left ventricular (LV) thrombus post-acute myocardial infarction (AMI) …

Aims Current guidelines recommend anticoagulation with a vitamin K antagonist to treat left
ventricular (LV) thrombus after myocardial infarction (MI). Data on the use of direct oral …

Post-ischemic left ventricular (LV) remodeling is a biologically complex process involving
myocardial structure, LV shape, and function, beginning early after myocardial infarction (MI) …

Abstract Background and Objectives The efficacy of direct oral anticoagulants (DOACs) in
the management of left ventricular (LV) thrombi remains to be determined, especially in …

Background Use of direct oral anticoagulants (DOACs) for the treatment of left ventricular
(LV) thrombus has gained considerable interest. Objective We aimed to evaluate if DOACs …

Current guidelines recommend vitamin K antagonists (VKAs) for the treatment of a left
ventricular thrombus (LVT). However, direct oral anticoagulants (DOACs) show superior …

Background The incidence of left ventricular thrombus (LVT) after anterior acute myocardial
infarction (AMI) has not been well established in the era of primary percutaneous coronary …

Left ventricular thrombus (LVT) is associated with inflammatory response in survivors with
anterior ST-elevation myocardial infarction (STEMI). The C-reactive protein to albumin ratio …

Objective In the current era of primary percutaneous coronary intervention (PPCI), the
prognosis of the left ventricular thrombus (LVT) is not well assessed. Methods We performed …